94% of researchers rate our articles as excellent or good
Learn more about the work of our research integrity team to safeguard the quality of each article we publish.
Find out more
ORIGINAL RESEARCH article
Front. Med.
Sec. Rheumatology
Volume 12 - 2025 | doi: 10.3389/fmed.2025.1558702
A correlation study of serum tumor markers with systemic lupus erythematosus-associated interstitial lung disease
Provisionally accepted
Xing He 1
Jiaqi Ji 2 Ting Zhou 2 Zeli Luo 3 Siyu Fang 2 Xixi Chen 2 Chi Liu 2 Haiying Yan 2
Lu Guo 2*- 1 West China Hospital, Sichuan University, Chengdu, Sichuan Province, China
- 2 Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
- 3 Wenjiang District People's Hospital, Chengdu, Sichuan Province, China
Systemic lupus erythematosus-associated interstitial lung disease (SLE-ILD) is a pulmonary manifestation of SLE. Currently, serum biomarkers for early identification of SLE-ILD are lacking. Our study aimed to investigate the correlation and clinical significance of serum tumor markers (TMs) in patients with SLE-ILD.We conducted a retrospective analysis of medical records from SLE patients between January 2017 and November 2023. we compared the differences in serum levels of TMs including carcinoembryonic antigen (CEA), carbohydrate antigens (CA125, CA15-3, and CA19-9), squamous cell carcinoma antigen (SCC), cytokeratin-19fragment (CYFRA21-1), neuron-specific enolase (NSE) and ferritin (FER), between SLE-ILD and SLE patients.A total of 386 SLE patients were enrolled in this study, comprising 64 individuals with SLE-ILD. Compared with SLE group, SLE-ILD group exhibited higher serum levels of CEA, CA125, CA15-3, CA19-9, SCC, CYFRA21-1, and FER. Multivariate regression indicated that age (OR=1.038, 95% CI= [1.004,1.074]), CA15-3 (OR=1.099, 95% CI= [1.039,1.162]), and CA19-9 (OR=1.032, 95% CI= [1.005,1.059]) were associated factors for SLE-ILD (P <0.05). Serum levels of CA15-3 demonstrated good diagnostic value with an area under the receiver operating characteristic curve (AUC)=0.72; furthermore, combining age with serum levels of CA19-9 and CA15-3 presented enhanced diagnostic performance as reflected by an AUC=0.80 (95% CI= [0.73,0.86]). Serum levels of SCC and CYFRA21-1 moderately positively correlated with serum creatinine levels (r = 0.562 and 0.713, respectively).Serum levels of CA125, CA15-3, and CA19-9 could act as associated markers for SLE-ILD. Serum SCC, CYFRA21-1 and FER levels may also be linked to kidney involvement in SLE-ILD.
Keywords: systemic lupus erythematosus, Interstitial Lung Disease, tumor markers, biomarkers, Organ involvement
Received: 10 Jan 2025; Accepted: 28 Feb 2025.
Copyright: © 2025 He, Ji, Zhou, Luo, Fang, Chen, Liu, Yan and Guo. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
Lu Guo, Sichuan Academy of Medical Sciences and Sichuan Provincial People's Hospital, Chengdu, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.